HLA-DMB expression by thyrocytes: indication of the antigen-processing andpossible presenting capability of thyroid cells

Citation
Z. Wu et al., HLA-DMB expression by thyrocytes: indication of the antigen-processing andpossible presenting capability of thyroid cells, CLIN EXP IM, 116(1), 1999, pp. 62-69
Citations number
45
Categorie Soggetti
Immunology
Journal title
CLINICAL AND EXPERIMENTAL IMMUNOLOGY
ISSN journal
00099104 → ACNP
Volume
116
Issue
1
Year of publication
1999
Pages
62 - 69
Database
ISI
SICI code
0009-9104(199904)116:1<62:HEBTIO>2.0.ZU;2-4
Abstract
Expression of HLA class II molecules on thyrocytes is a characteristic feat ure of autoimmune thyroid disease and may lead the thyroid cells to present autoantigens to CD4(+) T lymphocytes. Since HLA-DM is a critical molecule in class II-restricted antigen processing and presentation, we assessed the expression of HLA-DMB, -invariant chain (Ii), class II transactivator (CII TA) and DRA in an untransformed, pure thyrocyte strain HTV-59A. Here we rep ort that both HLA-DMB mRNA and the protein are expressed in thyrocytes and that CIITA expression is enhanced by interferon-gamma (IFN-gamma) treatment and occurs before DMB, Ii and DRA up-regulation, suggesting CIITA expressi on is a requirement for antigen processing in thyrocytes. These results ind icate that thyrocytes are capable of antigen processing and possibly antige n presentation to T cells.